Rolf W. Sparidans
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 41
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 19
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 16
- Hematology top 5%
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms 23
- PI3K/AKT/mTOR signaling in cancer 15
-
- HIV/AIDS drug development and treatment 21
-
- Lung Cancer Treatments and Mutations 18
-
- Pharmacological Effects and Toxicity Studies 16
- Co-authors
- Jos H. BeijnenAlfred H. SchinkelJan H.M. SchellensEls WagenaarIrene van den BroekJurjen S. LagasSelvi DurmuşJan den Hartigh
- Cited by
- OncologyPharmacologyGenetics
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Cancer Research (1 paper)
- Partner nations
- NetherlandsSpainUnited States
In The Last Decade
Rolf W. Sparidans
167 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 123
- Oncology 2.0k
- Pharmacology 426
- Genetics 436
- Hematology 307
- Molecular Biology 1.6k
Countries citing papers authored by Rolf W. Sparidans
This map shows the geographic impact of Rolf W. Sparidans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf W. Sparidans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf W. Sparidans more than expected).
Fields of papers citing papers by Rolf W. Sparidans
This network shows the impact of papers produced by Rolf W. Sparidans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf W. Sparidans. The network helps show where Rolf W. Sparidans may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rolf W. Sparidans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 19 | |
| 8 | 2019 | 15 | |
| 9 | 2019 | 10 | |
| 10 | 2017 | 23 | |
| 11 | 2016 | 64 | |
| 12 | 2016 | 39 | |
| 13 | 2016 | 31 | |
| 14 | 2015 | 47 | |
| 15 | 2015 | 41 | |
| 16 | 2014 | 31 | |
| 17 | 2013 | 130 | |
| 18 | 2012 | 102 | |
| 19 | 2010 | 151 | |
| 20 | 2004 | 17 |
About Rolf W. Sparidans
Rolf W. Sparidans is a scholar working on Oncology, Pharmacology and Virology, having authored 169 papers that have together received 4.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (41 papers), Cancer therapeutics and mechanisms (23 papers), HIV/AIDS drug development and treatment (21 papers), Pharmacogenetics and Drug Metabolism (19 papers), Lung Cancer Treatments and Mutations (18 papers), Chronic Lymphocytic Leukemia Research (16 papers), Pharmacological Effects and Toxicity Studies (16 papers) and PI3K/AKT/mTOR signaling in cancer (15 papers). The work is most often cited by research in Oncology (2.0k citations), Pharmacology (426 citations) and Genetics (436 citations). Rolf W. Sparidans has collaborated with scholars based in Netherlands, Spain and United States. Frequent co-authors include Jos H. Beijnen, Alfred H. Schinkel, Jan H.M. Schellens, Els Wagenaar, Irene van den Broek, Jurjen S. Lagas, Selvi Durmuş, Jan den Hartigh, Robert A.B. van Waterschoot and Johannes J.M. Rood. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.